1. OSHA inspectors will not only review your OSHA exposure control plan for completeness, but will conduct employee interviews to assess their understanding of your plan.
Circle One:
True --- False
2. Employers may permit employees to use their healthcare insurance
to pay for the Hepatitis B vaccine or post exposure followup.
Circle One: True --- False
3. OSHA approves over 300 safety devices for use in medical facilities.
Circle One:
True --- False
4. Gloves are usually not necessary when administering intramuscular
or subcutaneous injections as long as bleeding that could result in hand
contact with blood is not anticipated.
Circle One:
True --- False
5. Employers may be cited if employees are not wearing the correct
protective clothing (e.g., lab coat instead of a rubber apron) or if protective
clothing does not fit correctly (e.g., loose-fitting gloves).
Circle One:
True --- False
6. If an employee is allergic to a particular brand of glove, the
employer must provide an alternative.
Circle One:
True --- False
7. Employees who are allergic to latex may be provided with plastic
film (food-handling or cafeteria-style) gloves.
Circle One: True --- False
8. Lab bench surfaces must be decontaminated after each run and
when an employee leaves the work station.
Circle One:
True --- False
9. Employers are required to document only the route(s) of exposure
and the circumstances under which a needlestick occurs.
Circle One:
True --- False
10. Keep all MSDS for 30 years, or keep a list of all chemicals
or agents and where or when used, for 30 years.
Circle One:
True --- False
11. Employee training records must include the training date,
program content, trainer's name and qualifications, and names and job
titles of
all persons trained.
Circle One:
True --- False
12. You do not need to give OSHA inspectors access to employee
medical records.
Circle One:
True --- False
13. An injury for bloodborne pathogens standard purposes includes
needlesticks, splashes to non-intact skin, and lacerations.
Circle One:
True --- False
14. You do not need to keep the medical records of an employee
who remained in your employ less than one year if you turn them over to
the worker at departure time.
Circle One:
True --- False
15. Each year, exposure control plans must be updated and this
activity must be documented.
Circle One:
True --- False
16. Employees must have access to their own medical records and
may give written permission for others to see them.
Circle One:
True --- False
17. Employees obtained temporarily from a personnel service must be
offered the hepatitis B vaccine and post exposure evaluation and follow-up
at the facility's expense.
Circle One:
True --- False
18. The most common chronic bloodborne pathogen in the United States
is hepatitis B
Circle One:
True --- False
19. Laboratories that use glass capillary tubes could be cited
under the bloodborne pathogens standard.
Circle One:
True --- False
20. An exposure control plan may be maintained on a computer, but
a hard copy must be made available within 5 working days to employees
who request it.
Circle One:
True --- False
21. Regularly scheduled inspections of engineering controls are
required to confirm that they function as expected.
Circle One:
True --- False
22. Employers must test employees for Ab to HBsAg within one to
two months after the completion of the 3-dose vaccination series.
Circle One:
True --- False
23. After receiving the hepatitis B vaccine series, employees are
considered responders if they achieve anti-HBs >= 10 mIU/mL); inadequate
response to vaccination is serum anti-HBs <10 mIU/mL.
Circle One:
True --- False
24. Pre-vaccination screening for antibody status may be made available
to employees at no charge. Employees may decline this screening, and employers
must still make the hepatitis B vaccination available to them at no charge.
Circle One:
True --- False
25. After ten years post-vaccination, employees must receive boosters
for hepatitis B.
Circle One:
True --- False
26. You may not test post exposure employee blood samples in your
facility.
Circle One:
True --- False
27. Safety devices such as syringes, scalpels, and phlebotomy
equipment must be evaluated and implemented as they become commercially
available. Written evaluations
must be maintained in your Circle
One: True
--- False
28. During annual OSHA training sessions, employees must have
access to a qualified individual to answer their questions, either directly
or through a telephone hotline.
Circle One:
True --- False
29. The treatment for an exposed employee who was previously vaccinated
against hepatitis B and is a known responder is hepatitis B immune globulin.
Circle One:
True --- False
30. Hepatitis B immune globulin is the treatment of choice for
an unvaccinated employee who is exposed to a source patient whose hepatitis
B status is unknown.
Circle One:
True --- False
Answers:
1. True
2. True - But only if employers cover the cost of insurance plus
any copays or deductibles. No out of pocket expenses may be incurred by
employees.
3. False
- OSHA does not approve, endorse, register or certify medical devices.
4. True
5. True
6. True
7. False - These gloves are not considered appropriate for
bloodborne exposure-related tasks.
8. True
9. True
10. True
11. True
12. False - OSHA inspectors may review these records on site.
If requested, this review may occur under the observation of the medical
record holder (or other employer-designated healthcare professional).
The OSHA inspector may not record or take offsite any information from
the medical record other than documentation of the fact of compliance
or noncompliance.
13. True
14. True
15. True
16. True
17. False - While your facility exercises day-to-day supervision
over personnel service workers, they are the employees of both the facility
and the personnel service, and thus the facility must comply with all
of the provisions of the bloodborne pathogens standard with respect to
these
workers. With respect to hepatitis B vaccination and post exposure evaluation
and followup, your facility should take reasonable measures to ensure
that the personnel service firm has complied with these provisions.
18. False - According to the Centers for Disease Control and
Prevention (CDC), hepatitis C virus (HCV) is the most common chronic bloodborne
infection in the US.
19. True
20. False - A copy must be made available within 15 working
days of the employee's request.
21. True - Regularly scheduled inspections are required to
confirm, for instance, that engineering controls such as safer devices
continue to function effectively, that protective shields have not been
removed or broken, and that physical, mechanical or replacement-dependent
controls are functioning as needed.
22. True - The hepatitis B vaccination must be given in the
standard dose and through the standard route of administration as recommended
by the United States Public Health Services and CDC guidelines. The most
current CDC recommendation recommends employees post-vaccination testing
for hepatitis B surface antigen and re-vaccinating non-responders with
a second 3-dose vaccine series followed again by post vaccine testing
for HBsAg.
23. True
24. True
25. False - The provision of boosters for the hepatitis B
vaccine is under assessment by USPHS, but at this time is not recommended.
26. False - As long as the requirements for consent and confidentiality
have been followed, the employer's facility may be used for testing employees
post-exposure samples.
27. True - Your facility must have the most effective engineering
controls in use.
28. True
29. False - No treatment is required in this instance.
30. False - The hepatitis B vaccine series is the preferred
treatment.
Dr. Sheila Dunn is president and CEO of Quality America, Inc., a health care consulting firm through which she publishes instructional materials on OSHA and CLIA compliance and develops specialized sales, marketing, and training programs for major medical manufacturers and distributors. With a doctoral degree in medical laboratory education, Dr. Dunn is a widely respected lecturer and author of more than 200 articles on practice management and regulatory compliance issues for the primary care medical market. She is the editor of the subscription newsletter, OSHA Watch, and serves as an advisor to numerous national health care companies.
1-800-946-9956 -- www.quality-america.com
Copyright © Quality America, Inc. All Rights Reserved.
